Kurma Partners




Kurma Partners is a major player in the funding of healthcare and biotechnology in Europe. We invest at various stages of maturity, from company creation to capital expansion. Dedicated funds focus on novel therapeutic solutions, diagnostics, digital healthcare transformation, growth opportunities and sustainable agrifood technologies.

Upcoming events

Latest news

  • argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia

    20 hours ago

  • Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion

    Wednesday November 22nd 2023

  • argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis

    Thursday November 16th 2023